Swedbank Ab Seagen Inc. Transaction History

Swedbank Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Dec 09, 2024	SELL	$0.0 - $228.9 $0 - $1.27 Million	-5,547 Closed	0 $0
Q4 2022 Dec 09, 2024	SELL	$117.37 - $139.17 $3.48 Million - $4.12 Million	-29,612 Reduced 84.22%	5,547 $712,000
Q3 2022 Dec 09, 2024	BUY	$135.27 - $180.11 $3.13 Million - $4.16 Million	23,122 Added 192.09%	35,159 $4.81 Million
Q2 2022 Dec 09, 2024	BUY	$108.81 - $179.33 $44,829 - $73,883	412 Added 3.54%	12,037 $2.13 Million
Q2 2021 Dec 09, 2024	BUY	$135.08 - $161.1 $262,460 - $313,017	1,943 Added 20.07%	11,625 $1.84 Million
Q1 2021 Dec 09, 2024	BUY	$137.51 - $190.8 $1.33 Million - $1.85 Million	9,682 New	9,682 $1.34 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.